Q32 Bio Inc. (QTTB)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Q32 Bio Inc. reported revenue of $53.74M. The company was profitable, with a net margin of 55.5%. It held $61.78M in total assets against $19.76M in total liabilities.
Key ratios (FY2025)
31.5%
Operating margin
55.5%
Net margin
71.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.74M | $0 | -$6.65M | — | — | — | — | $3.68M | — | — |
| Operating Income | $16.90M | -$66.10M | -$48.26M | -$133.28M | -$95.95M | -$130.26M | -$109.94M | -$59.93M | -$29.66M | — |
| Net Income | $29.82M | -$47.73M | -$53.74M | -$5.00M | -$95.76M | -$128.69M | -$103.92M | -$55.58M | -$29.99M | — |
| EPS (Diluted) | $2.42 | $-6.58 | $-153.96 | $-0.09 | $-1.73 | — | — | — | — | — |
| Total Assets | $61.78M | $92.33M | $47.06M | $228.47M | $211.72M | $263.74M | $310.57M | $259.09M | $137.53M | — |
| Total Liabilities | $19.76M | $86.66M | $118.53M | $50.49M | $42.07M | $67.74M | $52.06M | $62.74M | $39.22M | — |
| Shareholders' Equity | $42.01M | $5.67M | -$182.92M | -$130.71M | $169.65M | $196.00M | $258.51M | $196.35M | -$39.45M | -$9.89M |
| Cash & Equivalents | $48.30M | $77.97M | $25.62M | $33.99M | $108.38M | $217.43M | $53.77M | $38.22M | $51.58M | $11.39M |
| Operating Cash Flow | -$33.54M | -$67.72M | -$18.68M | -$113.66M | -$109.75M | -$94.33M | -$91.36M | -$42.56M | $6.48M | — |
| Capital Expenditures | $0 | $75.0K | $5.0K | $1.28M | $2.40M | $3.73M | $21.83M | $24.94M | $1.96M | — |
| Shares Outstanding | 12.86M | 12.20M | 359.6K | 57.48M | 57.15M | 50.27M | 45.12M | 37.36M | 2.64M | — |